Pilot Study: MaxPlus PharmaPack SP™ Shipper Evaluation by Specialty Pharmacies
The trend toward direct-to-patient specialty medication delivery has been growing for several years, which has only been accelerated by COVID-19 restrictions. These medications are often biologics and must be kept within strict temperature ranges. For specialty pharmacies this has meant purchasing and storing bulky, expensive, and single-use packaging solutions – cumbersome for both pharmacists and patients – and incurring increasing inbound and outbound freight costs, as well as negative environmental impact.
